Close Menu

NEW YORK – Fluorescent dye maker Phitonix said today that it has raised $2 million in a seed funding round. 

The Durham, North Carolina-based firm has developed a nanotechnology platform that allows precise engineering of fluorescent nanoparticles called Phitons with specific optical properties to provide high-resolution analysis of single cells by high-throughput flow cytometry. 

Phitonex said that the seed round was led by private investors. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.